Chugai Pharmaceutical Co., Ltd. (CHGCY)

OTC Markets OTCPK • Currently down 0.48 (-1.72%) in today's trading session

1 member of Congress has disclosed 5 trades in Chugai Pharmaceutical Co., Ltd. (CHGCY) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 9 April 2025. Aggregate disclosed activity totals roughly $24K in sales (midpoint estimates from bracketed disclosure amounts).

Chugai Pharmaceutical Co., Ltd. is currently trading at $27.40, positioned at 51% of its 52-week range ($19.50 – $34.84).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$27.40
24h Change
-0.48 (-1.72%)
52 Week Range
$19.50—$34.84
View on NASDAQ

Chugai Pharmaceutical Co., Ltd. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CHGCY

Select to highlight on chart
4 transactions
Compliance: 80%
Josh Gottheimer9 Apr 202514 May 2025SaleOptions$1,001 - $15,000N/A
Josh Gottheimer21 Jun 20249 Jul 2024SaleStock$1,001 - $15,000N/A
Josh Gottheimer21 Jun 202411 Aug 2025Stock$1,001 - $15,000N/A
Josh Gottheimer4 Apr 202415 May 2024SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$91.76B

Volume

8.14K

Beta

0.60

P/E Ratio

33.59

Fundamentals

EPS

$0.83

Div. Yield

2.95%

Open

$29.03

Day Range

$27.11 — $29.03

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTC · USD
Country
JP
CEO
Osamu Okuda
IPO Date
2012-08-03
Website
www.chugai-pharm.co.jp

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily in...

Earnings

Recent Quarters

Q1 202622 Apr
EPS—
Q4 202529 Jan
EPS$0.25
Q3 202524 Oct
EPS$0.23
Q2 202524 Jul
EPS$0.20
Q1 202524 Apr
EPS$0.19
Q4 202430 Jan
EPS$0.18
Q3 202425 Oct
EPS$0.22
Q2 202425 Jul
EPS$0.22
Q1 202424 Apr
EPS$0.15
Q4 20231 Feb
EPS$0.19
Beat 5.6%
Q3 202324 Oct
EPS$0.16
Q2 202327 Jul
EPS$0.18
Q1 202327 Apr
EPS$0.17
Q4 20222 Feb
EPS$0.22
Q3 202224 Oct
EPS$0.15
Miss 11.8%
Q2 202221 Jul
EPS$0.17
Q1 202225 Apr
EPS$0.34
Q3 202131 Dec
EPS$0.26
Q3 202122 Oct
EPS$0.24
Q1 202130 Jun
EPS$0.19
Q4 202031 Mar
EPS$0.13
Q3 202031 Dec
EPS$0.15
Q2 202030 Sept
EPS$0.17
Q2 202027 Jul
EPS$30.89
Miss 1.4%
Q1 202023 Apr
EPS$31.37
Beat 3.6%
Q4 201930 Jan
EPS$24.46
Miss 1.5%
Q3 201924 Oct
EPS$29.31
Beat 40.9%
Q2 201925 Jul
EPS$20.84
Beat 17.5%
Q1 201924 Apr
EPS$21.34
Beat 14.9%
Q4 201831 Jan
EPS$13.49
Q3 201824 Oct
EPS$13.20
Miss 5.2%
Q2 201826 Jul
EPS$12.67
Beat 15.9%
Q1 201824 Apr
EPS$51.00
Beat 7.8%
Q4 20171 Feb
EPS$28.38
Miss 14.7%
Q3 201725 Oct
EPS$38.59
Beat 31.5%
Q2 201727 Jul
EPS$32.21
Miss 3.7%
Q1 201725 Apr
EPS$33.86
Q4 20161 Feb
EPS$19.23
Beat 1.2%
Q3 201625 Oct
EPS$21.12
Miss 13.8%
Q2 201621 Jul
EPS$31.22
Q1 201622 Apr
EPS$26.55
Q4 201528 Jan
EPS$24.69
Beat 3.6%
Q3 201522 Oct
EPS$32.07
Beat 16.1%
Q2 201523 Jul
EPS$28.45
Beat 56.3%
Q1 201522 Apr
EPS$26.73
Miss 2.8%
Q4 201428 Jan
EPS$0.03
Q3 201424 Oct
EPS$0.03
Q1 201430 Jun
EPS$0.03
Q4 201331 Mar
EPS$0.06
Q3 201331 Dec
EPS$0.04
Q2 201330 Sept
EPS$0.04
Q1 201330 Jun
EPS$0.05
Q4 201231 Mar
EPS$0.03
Q3 201231 Dec
EPS$0.07
Q2 201230 Sept
EPS$0.04
Q1 201230 Jun
EPS$0.04
Q4 201131 Mar
EPS$0.03
Q3 201131 Dec
EPS$0.03
Q2 201130 Sept
EPS$0.04
Q1 201130 Jun
EPS$0.05
Q4 201031 Mar
EPS$0.02
Q3 201031 Dec
EPS$0.05
Q2 201030 Sept
EPS$0.04
Q1 201030 Jun
EPS$0.03
Q4 200931 Mar
EPS$0.03
Q3 200931 Dec
EPS$0.05
Q2 200930 Sept
EPS$0.05
Q1 200930 Jun
EPS$0.04
Q4 200831 Mar
EPS$0.04

3 politicians traded within 30 days

Dividends

Next Dividend

Ex-Date

29 Jun 2026

Amount

$0.4175 per share

Yield

3.00%

Days Until

66

Pay Date:28 Aug 2026
Record Date:30 Jun 2026

Dividend History

29 Dec 2025
Amount $0.4130
30 Jun 2025
Amount $0.4088
31 Dec 2024
Amount $0.1278
28 Jun 2024
Amount $0.1150
28 Dec 2023
Amount $0.1322
29 Jun 2023
Amount $0.1373
29 Dec 2022
Amount $0.1504
29 Jun 2022
Amount $0.1369
29 Dec 2021
Amount $0.1887
28 Jun 2021
Amount $0.1365
29 Dec 2020
Amount $0.1380
26 Jun 2020
Amount $0.1186
27 Dec 2019
Amount $0.1426
26 Jun 2019
Amount $0.0754
27 Dec 2018
Amount $0.0827
27 Jun 2018
Amount $0.0466
27 Dec 2017
Amount $0.0524
27 Jun 2017
Amount $0.0439
28 Dec 2016
Amount $0.0391
28 Jun 2016
Amount $0.0417
29 Dec 2015
Amount $0.0471
25 Jun 2015
Amount $0.0362
26 Dec 2014
Amount $0.4365
25 Jun 2014
Amount $0.4191
27 Dec 2013
Amount $0.4492
25 Jun 2013
Amount $0.4478
14 Sept 2012
Amount $0.6412

Stock Splits

Split History

6 Jul 2020Stock Split
Ratio12:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about CHGCY

Which members of Congress have traded CHGCY?
1 member of Congress has disclosed 5 trade in Chugai Pharmaceutical Co., Ltd. (CHGCY) under the STOCK Act: Josh Gottheimer.
When was CHGCY most recently disclosed by Congress?
The most recent CHGCY disclosure was a sale by Josh Gottheimer on 9 April 2025.
What is the total disclosed congressional trading volume for CHGCY?
Members of Congress have disclosed approximately $24K in CHGCY sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in CHGCY?
This CHGCY page updates as soon as new STOCK Act disclosures are filed for Chugai Pharmaceutical Co., Ltd.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi TrackerJoin our Discord
PoliticiansPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.